Category: CNS/Neurology
CNS/Neurology market research reports by GlobalData
-
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031 Summary Schizophrenia is a chronic and debilitating mental illness, characterized by delusions, hallucinations, disorganized speech, trouble with thinking, and a lack of motivation. It is among the most disabling and economically catastroph ... Read More
-
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Major Depressive Disorder therapeutics. Synopsis In 2022, there will be more than 18 mil ... Read More
-
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Tr ... Read More
-
Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Co ... Read More
-
Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type ... Read More
-
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Social Anxiety Disorder (SAD Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Social Anxiety Disorder (SAD Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Social Anxiety Disorder (SAD Social Phobia) Clinical Trial Analysis by Trial P ... Read More
-
Neuroimmunology Drug Development - Thematic Research
Neuroimmunology Drug Development - Thematic Research Summary This report provides an overview of neuroimmunology drug development within eight key indications across eight pharmaceutical markets. The neuroimmune system is complex and a critical component in regulating nervous system health and disea ... Read More
-
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Anxiety therapeutics. Synopsis In 2022, there will be more than 291 million pre ... Read More
-
Carpal Tunnel Syndrome - Global Clinical Trials Review, 2022
Carpal Tunnel Syndrome - Global Clinical Trials Review, 2022 Summary GlobalData's clinical trial report, “Carpal Tunnel Syndrome - Global Clinical Trials Review, 2022 provides an overview of Carpal Tunnel Syndrome Clinical trials scenario. This report provides top line data relating to the clinical ... Read More
-
Alcohol Addiction - Global Clinical Trials Review, 2022
Alcohol Addiction - Global Clinical Trials Review, 2022 Summary GlobalData's clinical trial report, “Alcohol Addiction - Global Clinical Trials Review, 2022 provides an overview of Alcohol Addiction Clinical trials scenario. This report provides top line data relating to the clinical trials on Alcoh ... Read More
-
Bipolar Disorder - Global Drug Forecast and Market Analysis to 2030
Bipolar Disorder - Global Drug Forecast and Market Analysis to 2030 Summary Bipolar disorder, known originally as manic-depressive illness, is a mental disorder characterized by periods of mania and depression. Manic episodes are the distinguishing feature of this condition and consist of an abnorma ... Read More
-
Autism - Global Clinical Trials Review, 2022
Autism - Global Clinical Trials Review, 2022 Summary GlobalData's clinical trial report, “Autism - Global Clinical Trials Review, 2022 provides an overview of Autism Clinical trials scenario. This report provides top line data relating to the clinical trials on Autism. Report includes an overview of ... Read More
Research Assistance
